Ultragenyx Pharmaceutical Inc. appointed Deborah Dunsire to the company's board of directors.
Dunsire, currently president and CEO of XTuit Pharmaceuticals Inc., will serve as an independent director on Ultragenyx's board.
Discover more about S&P Global’s offerings